Sunday, October 12

7:00 am - 6:00 pm

Registration Open

7:00 am - 7:30 am


7:30 am - 8:45 am

General Session


Reducing the Overall Risk of Cardiovascular Morbidity and Mortality in the CKD Population

1.25 CH, 1.25 Rx

Supported by an educational grant from Sanofi Renal

Orlando M. Gutierrez, MD, MMSc

  • Analyze the laboratory values that can impact the development of hypercalcemia, hyperlipidemia and systemic inflammatory markers in the CKD patient.
  • Discuss the risk factors that can impact the development of hypercalcemia, hyperlipidemia and systemic inflammatory markers in the CKD patient.
  • Recognize effective treatment strategies to minimize hypercalcemia, hyperlipidemia and systemic inflammatory markers in the individual with CKD or incident to hemodialysis/peritoneal dialysis.

8:45 am - 9:45 am

Exhibits Open / Coffee Break

10:00 am - 11:30 am

Concurrent Sessions (111-114)


It Starts with a Spark


Kristin Larson, MSN, RN, ANP, GNP, CNN

  • Compare and contrast the concepts of precepting, orienting, and mentoring.
  • Incorporate generational characteristics and outline mentoring strategies for nurses of all age groups.
  • Through case studies, outline a mentoring plan for nephrology nurses new to practice and seasoned in practice.


You Take My Breath Away

1.5 CH.5 RxRN

Judy Kauffman, MSN, RN, CNN
Mary Perrecone, MS, RN, CCRN, CNN

  • Define hypoxia and the physiologic responses to hypoxia.
  • Discuss causes and effects of hypoxia in the person with CKD.
  • Compare and contrast various techniques for measuring hypoxia.
  • Describe strategies to prevent and treat hypoxia.


Blurred Lines: Primary Care in Dialysis

1.5 CH.5 RxAPN

Lisa Koester, MSN, ANP, CNN-NP

  • Describe the role of the nephrology APN in providing primary care.
  • Discuss the challenges to providing primary care for dialysis patients.
  • Explore the pros and cons of providing primary care for dialysis patients.


Should Kids Go to the Front of the Line: Controversies in Transplant

1.5 CHHT

Kenneth Andreoni, MD

  • Analyze the ethical implications of a recent case study involving a pediatric lung transplant.
  • Explain the current organ allocation policy related to the prioritization of the pediatric transplant candidate.
  • Explore the impact of the proposed changes in kidney transplant allocation policies.

11:30 am - 12:30 pm

Exhibits Open / Coffee Break

12:45 pm - 1:15 pm


1:15 pm - 2:30 pm

General Session


Biosimilar Medications: What Nephrology APNs and Nurses Need to Know

1.25 CH, 1.25 Rx

Supported by an educational donation from Amgen

Tracy Anderson-Haag, PharmD, BCPS

  • Discuss the origins of biopharmaceutical and biosimilar medications.
  • Examine the technology that has led to the development of biosimilars in immunologic therapies and in anemia management.
  • Review the important differences between generic medications and biosimilar agents.
  • Discuss strategies that can be implemented to successfully improve patient safety when utilizing biosimilar agents.

2:45 pm - 4:15 pm

Concurrent Sessions (131-134)


Recognizing and Rewarding Excellence in YOUR Setting


Mary Robinson, PhD, RN, NEA-BC

  • Discuss the initial research and the outcomes (relevance) of the Magnet approach/perspective to outpatient settings.
  • Identify the "attractive" positive effects of implementing Magnet concepts in the work setting.
  • Determine how to implement a nursing excellence program in a dialysis patient care setting.


Fred Is Missing: Dealing with Death in the Dialysis Unit

1.5 CHRN

Mary Haras, PhD, MS, MBA, APN, NP-C, CNN

  • Assess the impact of grief and loss on patients and staff.
  • Develop strategies to support healthy methods of grieving among individuals affected by the loss.
  • Discuss ways to allow expressions of grief that maintain professional behavior.


Osteoporosis in CKD

1.5 CH1.5 RxAPN

Ann Hallock, DNP, APRN, CNP, CNN

  • Identify the pathophysiologic changes seen in osteoporosis.
  • Discuss the pharmacologic therapies for the treatment of osteoporosis.
  • Determine the implications of the management of osteoporosis as the glomerular filtration rate declines.


Confusion on Transfusion

1.5 CH.5 RxHT

Debbie Ashton, BSN, RN, CNN

  • Identify the indications for transfusion in the individualwith CKD.
  • Describe the potential complications of a transfusion.
  • Discuss best practices in the administration of transfusions in the individual with CKD.

4:30 pm - 6:00 pm

Concurrent Sessions (141-144)


Financial Exploitation in ESRD


Lisa Zokas Kindy, JD

  • Describe situations of financial exploitation.
  • Identify signs of possible financial exploitation.
  • Examine the nurse's legal responsibilities in addressing suspected incidences of financial exploitation.


Is There an App for That? Renal Applications

1.5 CHRN

LaTricia Perry, MSN, RN

  • Analyze how access to information has changed with the use of portable devices.
  • Explore software applications for portable devices useful for nephrology practice.
  • Describe the inclusion of the patient perspective on the use of software applications.
  • Appraise the validity of the content of software applications.


Peri, Endo, and Myocarditis: Knowing the Cardiac "itis"

1.5 CH1.5 RxAPN

Paul St. Laurent, DNP, RN, ACNP-BC, CCRN-CMC

  • Discuss the etiology of endocarditis, pericarditis, and myocarditis in individuals with CKD.
  • Analyze assessment and diagnostic study findings that differentiate among endocarditis, pericarditis, and myocarditis.
  • Select treatment strategies for cardiac inflammation and infection.


Hypercholesterolemia / Lipid Apheresis

1.5 CH1.5 RxHT

Lynne Braun, PhD, CNP, FAHA

  • Discuss the pathophysiology of hypercholesterolemia.
  • Review the disorders that contribute to hypercholesterolemia.
  • Identify treatment strategies to lower cholesterol.
  • Modify treatment of hypercholesterolemia based upon CKD stage or treatment modality.

> View the schedule for Saturday View the schedule for Monday >